Literature DB >> 17991864

Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.

Xiaochun Bai1, Dongzhu Ma, Anling Liu, Xiaoyun Shen, Qiming J Wang, Yongjian Liu, Yu Jiang.   

Abstract

The mammalian target of rapamycin, mTOR, is a central regulator of cell growth. Its activity is regulated by Rheb, a Ras-like small guanosine triphosphatase (GTPase), in response to growth factor stimulation and nutrient availability. We show that Rheb regulates mTOR through FKBP38, a member of the FK506-binding protein (FKBP) family that is structurally related to FKBP12. FKBP38 binds to mTOR and inhibits its activity in a manner similar to that of the FKBP12-rapamycin complex. Rheb interacts directly with FKBP38 and prevents its association with mTOR in a guanosine 5'-triphosphate (GTP)-dependent manner. Our findings suggest that FKBP38 is an endogenous inhibitor of mTOR, whose inhibitory activity is antagonized by Rheb in response to growth factor stimulation and nutrient availability.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991864     DOI: 10.1126/science.1147379

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  162 in total

1.  Mammalian target of rapamycin in spinal cord neurons mediates hypersensitivity induced by peripheral inflammation.

Authors:  E Norsted Gregory; S Codeluppi; J A Gregory; J Steinauer; C I Svensson
Journal:  Neuroscience       Date:  2010-06-09       Impact factor: 3.590

2.  RHEB/mTOR hyperactivity causes cortical malformations and epileptic seizures through increased axonal connectivity.

Authors:  Martina Proietti Onori; Linda M C Koene; Carmen B Schäfer; Mark Nellist; Marcel de Brito van Velze; Zhenyu Gao; Ype Elgersma; Geeske M van Woerden
Journal:  PLoS Biol       Date:  2021-05-26       Impact factor: 8.029

Review 3.  Hold me tight: Role of the heat shock protein family of chaperones in cardiac disease.

Authors:  Monte S Willis; Cam Patterson
Journal:  Circulation       Date:  2010-10-26       Impact factor: 29.690

4.  The FKBP38 catalytic domain binds to Bcl-2 via a charge-sensitive loop.

Authors:  Katja Haupt; Günther Jahreis; Miriam Linnert; Mitcheell Maestre-Martínez; Miroslav Malesevic; Arndt Pechstein; Frank Edlich; Christian Lücke
Journal:  J Biol Chem       Date:  2012-04-20       Impact factor: 5.157

Review 5.  mTOR signaling in cancer cell motility and tumor metastasis.

Authors:  Hongyu Zhou; Shile Huang
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

6.  Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell death.

Authors:  Long Chen; Baoshan Xu; Lei Liu; Yan Luo; Hongyu Zhou; Wenxing Chen; Tao Shen; Xiuzhen Han; Christopher D Kontos; Shile Huang
Journal:  Free Radic Biol Med       Date:  2010-12-30       Impact factor: 7.376

7.  The Rheb-mTOR pathway is upregulated in reactive astrocytes of the injured spinal cord.

Authors:  Simone Codeluppi; Camilla I Svensson; Michael P Hefferan; Fatima Valencia; Morgan D Silldorff; Masakatsu Oshiro; Martin Marsala; Elena B Pasquale
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

Review 8.  PI3K/mTORC1 activation in hamartoma syndromes: therapeutic prospects.

Authors:  Vera P Krymskaya; Elena A Goncharova
Journal:  Cell Cycle       Date:  2009-02-06       Impact factor: 4.534

9.  The myonuclear DNA methylome in response to an acute hypertrophic stimulus.

Authors:  Ferdinand Von Walden; Matthew Rea; C Brooks Mobley; Yvonne Fondufe-Mittendorf; John J McCarthy; Charlotte A Peterson; Kevin A Murach
Journal:  Epigenetics       Date:  2020-04-28       Impact factor: 4.528

10.  Bifenthrin causes transcriptomic alterations in mTOR and ryanodine receptor-dependent signaling and delayed hyperactivity in developing zebrafish (Danio rerio).

Authors:  Daniel F Frank; Galen W Miller; Danielle J Harvey; Susanne M Brander; Juergen Geist; Richard E Connon; Pamela J Lein
Journal:  Aquat Toxicol       Date:  2018-04-18       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.